Open AccessSystemic chemotherapy and tamoxifen induced regression of choroidal metastasis from a breast carcinoma in a male
Author(s) -
Debraj Shome,
Chaitra Jayadev,
Darshana Gadgil,
Sundaram Natarajan,
Vandana Jain
Publication year - 2007
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.36491
Subject(s) - medicine , tamoxifen , oncology , breast carcinoma , chemotherapy , carcinoma , metastasis , breast cancer , cancer
We report a case of a 55-year-old male patient with breast carcinoma, who developed choroidal metastasis. The patient had undergone mastectomy for carcinoma of right breast, five years ago. The patient was advised close follow-up for the left eye, as he was already on tamoxifen therapy (started a month ago) for spinal metastasis. On last follow-up, a year later, the choroidal lesion had completely scarred, with no recurrences. Systemic hormonal therapy like tamoxifen given for the breast primary and other systemic metastases may cause regression of the choroidal metastasis, thereby avoiding ocular radiotherapy. Medline search revealed only one published case of regression of choroidal metastasis from a male breast primary, on tamoxifen therapy.